Scinovex
article Open AccessTop 1% cited

p63, a p53 Homolog at 3q27–29, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative Activities

Molecular Cell · 1998 · Vol. 2(3) · pp. 305–316
Annie YangMourad KaghadYunmei WangEmily S. GillettMark D. FlemingVolker DötschNancy C. AndrewsDaniel CaputFrank McKeon
Cancer-related Molecular PathwaysCancer Research and TreatmentsMolecular Biology Techniques and ApplicationsBiologyTransactivationGeneCell biologyTumor suppressor geneMutantCancer researchHomology (biology)Epidermis (zoology)Apoptosis

MeSH terms

Amino Acid SequenceAnimalsChromosome MappingChromosomes, Human, Pair 3Crosses, GeneticDNA-Binding ProteinsFemaleHumansIntronsMaleMembrane ProteinsMice, Inbred C57BLMolecular Sequence DataMuridaePhosphoproteins

Funding

  • American Cancer Society
  • National Institutes of Health
Citations
2,069
FWCI
28.13
field-weighted impact
References
42
Percentile
100%
vs. same field & year
Citations per year
Cited by
The p53 pathway
The Journal of Pathology · 1999 · 1,303 citations
p63 Is a Prostate Basal Cell Marker and Is Required for Prostate Development
American Journal Of Pathology · 2000 · 608 citations
p53 Family and Cellular Stress Responses in Cancer
Frontiers in Oncology · 2014 · 289 citations
References
p53 Mutations in Human Cancers
Science · 1991 · 8,098 citations
p53: puzzle and paradigm.
Genes & Development · 1996 · 2,349 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.